help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanukoglu, A.
Right arrow Articles by Daneman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanukoglu, A.
Right arrow Articles by Daneman, D.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 1 186-191
Copyright © 2001 by The Endocrine Society


Original Studies

Relationship of Etiology to Treatment in Congenital Hypothyroidism

Aaron Hanukoglu, Kusiel Perlman, Igor Shamis, Lori Brnjac, Joanne Rovet and Denis Daneman

Division of Endocrinology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada M5G 1X8; and Department of Pediatrics, E. Wolfson Medical Center and Tel-Aviv University Sackler School of Medicine, Tel-Aviv, Israel 69978

Address all correspondence and requests for reprints to: Dr. Denis Daneman, Division of Endocrinology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. E-mail: denis.daneman{at}sickkids.on.ca

We examined the patterns of TSH, T4, and treatment schedules from diagnosis to 4 yr of age in 125 children (50 males anf 75 females) with congenital hypothyroidism (CH). Subjects were divided into 3 groups based on their thyroid scans: 1) athyreosis (n = 31), 2) dysgenesis (n = 54; 49 lingual and 5 hypoplastic), and 3) dyshormonogenesis (n = 40). Follow-up evaluation was carried out at 2–4 wk and 3, 6, 9, 12, 24, 36, and 48 months of age. Median gestational age, age at onset of therapy, and starting L-T4 dose were similar in the three groups. In infants with athyreosis median screening TSH levels were higher (P < 0.02) and confirmatory T4 levels were lower than in the other two groups (P < 0.01 vs. dysgenetic; P < 0.05 vs. dyshormonogenetic CH). During the first 6 months of therapy, mean TSH levels were highest in the athyrotic group, intermediate in the dysgenetic group, and lowest in the dyshormonogenetic group. In children with athyreosis, TSH levels normalized by 12 months of age. At 12 months dysgenetic patients had the highest TSH levels (P < 0.05). During the entire study period, TSH levels were lowest in patients with dyshormonogenesis (except at 48 months) and normalized earlier. Mean T4 levels normalized by 2–4 weeks in all groups. At 3 and 6 months, the percentage of patients who required dose changes was highest in the athyrotic group, and at 12 months it was highest in the dysgenetic group. The athyrotic group received the highest dose of L-T4, and dyshormonogenetic group received the lowest dose. We conclude that treatment and follow-up schedules for CH may differ in the three etiological categories based on the different hormonal patterns and responses to therapy. Children with athyreosis need close monitoring particularly early in life, whereas those with dysgenesis and dyshormonogenesis require more attention later in life.




This article has been cited by other articles:


Home page
J Trop PediatrHome page
R. Iranpour, M. Hashemipour, M. Amini, S. M. Talaei, R. Kelishadi, S. Hovsepian, S. Haghighi, and Kh. Khatibi
[Tc]-99m Thyroid Scintigraphy in Congenital Hypothyroidism Screening Program
J Trop Pediatr, December 1, 2006; 52(6): 411 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. E. Kempers, A. S. P. van Trotsenburg, D. A. van Tijn, E. Bakker, B. M. Wiedijk, E. Endert, J. J. M. de Vijlder, and T. Vulsma
Disturbance of the Fetal Thyroid Hormone State Has Long-Term Consequences for Treatment of Thyroidal and Central Congenital Hypothyroidism
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4094 - 4100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Eugene, A. Djemli, and G. Van Vliet
Sexual Dimorphism of Thyroid Function in Newborns with Congenital Hypothyroidism
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2696 - 2700.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Ohnishi, H. Sato, H. Noda, H. Inomata, and N. Sasaki
Color Doppler Ultrasonography: Diagnosis of Ectopic Thyroid Gland in Patients with Congenital Hypothyroidism Caused by Thyroid Dysgenesis
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5145 - 5149.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Van Vliet, B. Larroque, L. Bubuteishvili, K. Supernant, and J. Leger
Sex-Specific Impact of Congenital Hypothyroidism due to Thyroid Dysgenesis on Skeletal Maturation in Term Newborns
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2009 - 2013.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society